期刊文献+

阿托伐他汀对急性冠状动脉综合征患者不对称二甲基精氨酸的影响

Effect of atorvastatin on level of asymmetric dimethylarginine of patients with acute coronary syndrome
在线阅读 下载PDF
导出
摘要 目的研究阿托伐他汀对急性冠状动脉综合征(ACS)患者不对称二甲基精氨酸(ADMA)的影响及意义。方法随机选择ACS患者78例,入选后再随机分为阿托伐他汀组(他汀组)39例,常规治疗组(常规组)39例;随机选取我院同期的健康体检者40例作对照组。测定每组治疗前后血脂和ADMA水平。结果①急性心肌梗死(AMI)组ADMA浓度(1.09±0.36)μmol/L高于不稳定型心绞痛(UAP)组(0.91±0.22)μmol/L(P<0.01),AMI组和UAP组ADMA浓度高于正常对照组(0.57±0.12)μmol/L(P<0.01)。②他汀组经阿托伐他汀治疗后,ADMA、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)均低于治疗前,分别为ADMA(0.67±0.25)μmol/L vs(1.02±0.32)μmol/L,TC(5.26±0.78)mmol/L vs(6.86±1.09)mmol/L,TG(1.58±0.45)mmol/L vs(2.06±0.37)mmol/L,LDL-C(2.51±0.48)mmol/L vs(2.97±0.45)mmol/L(P<0.01);常规组治疗后以上指标降低不多,他汀组治疗后ADMA、TC、TG、LDL-C均低于常规组。结论阿托伐他汀可能通过调节ACS患者血浆血脂水平,进而降低ADMA的生成。 Objective To investigate the effect of atorvastatin on level of asymmetric dimethylarginine(ADMA) of patients with acute coronary syndrome and its significance.Methods 78 patients with acute coronary syndrome were divided into two groups at random,respectively atorvastatin therapy group and conventional therapy group,and 40 healthy subjects served as control group.The levels of TC,TG,LDL-C,HDL-C and ADMA were measured before and after treatment.Results ①The level of ADMA of the patients of AMI(1.09±0.36) μmol/L was higher than that of the patients of UAP(0.91±0.22) μmol/L(P〈0.01),and the levels of ADMA of above two groups were higher than that of control group(0.57±0.12) μmol/L(P〈0.01).②After treatment for four weeks,the levels of ADMA,TC,TG and LDL-C in atorvastatin therapy group were all significantly lower than those before treatment,ADMA(0.67±0.25) μmol/L vs(1.02±0.32) μmol/L,TC(5.26±0.78) mmol/L vs(6.86±1.09) mmol/L,TG(1.58±0.45) mmol/L vs(2.06±0.37) mmol/L,LDL-C(2.51±0.48) mmol/L vs(2.97±0.45) mmol/L(P〈0.01).The levels of above indexes were not decreased significantly in conventional therapy group after treament,and the levels of ADMA,TC,TG and LDL-C in atorvastatin therapy group were all lower than those in conventional therapy group after treatment.Conclusion Atorvastatin can decrease the level of ADMA of patients with acute coronary syndrome by regulating serum lipid proteins.
出处 《临床荟萃》 CAS 2010年第13期1107-1109,共3页 Clinical Focus
关键词 冠状动脉疾病 精氨酸 色谱法 凝胶 coronary disease arginine chromatography gel
  • 相关文献

参考文献12

  • 1Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s[J]. Nature,1993,362(6423) :801-809.
  • 2Boger RH. The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor[J].Cardiovasc Res, 2003, 59(4) : 824-833.
  • 3Kinlay S, Selwyn AP, Delagrange D, el al. Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end-points[J]. Curr Opin Lipidol,1996,7(6):389-397.
  • 4Lu TM, Ding YA, Charng MJ, el al. Asymmetrical dimethylarginine:a novel risk factor for coronary artery disease [J].Clin Cardiol, 2003,26 (10) : 458-464.
  • 5Krempl TK,Maas R, Sydow K, et al. Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events[J].Eur Heart J,2005,26(18):1846- 1851.
  • 6Schulze F, Lenzen H, Hanefeld C, et al. Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration(CARDIAC) study[J]. Am Heart J, 2006,152 (3) 493,e1-8.
  • 7黄日茂,蒋海河,罗万俊,林国强,李迎秋.冠心病患者血清非对称二甲基精氨酸水平与冠状动脉狭窄程度的相关性[J].中国动脉硬化杂志,2008,16(7):549-552. 被引量:7
  • 8郑平,莫茹,毕磊.阿托伐他汀治疗老年高脂血症患者的疗效观察[J].中国实用医药,2009,4(4):150-151. 被引量:2
  • 9靖美玲,杨雅娟,韩文生.阿托伐他汀对急性冠脉综合征治疗效果观察[J].中国误诊学杂志,2009,9(25):6075-6076. 被引量:2
  • 10邓珊,秦超.不对称二甲基精氨酸与心脑血管疾病[J].临床荟萃,2008,23(14):1059-1061. 被引量:3

二级参考文献44

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部